(Q24815007)

English

Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 July 2017

Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines (English)

1 reference

Europe PubMed Central

4 July 2017

author name string

Da Yong Lu

1

1 reference

Europe PubMed Central

4 July 2017

Min Huang

2

1 reference

Europe PubMed Central

4 July 2017

Cheng Hui Xu

3

1 reference

Europe PubMed Central

4 July 2017

Wei Yi Yang

4

1 reference

Europe PubMed Central

4 July 2017

Chao Xin Hu

5

1 reference

Europe PubMed Central

4 July 2017

Li Ping Lin

6

1 reference

Europe PubMed Central

4 July 2017

Lin Jiang Tong

7

1 reference

Europe PubMed Central

4 July 2017

Mei Hong Li

8

1 reference

Europe PubMed Central

4 July 2017

Xiong Wen Zhang

10

1 reference

Europe PubMed Central

4 July 2017

Jian Ding

11

1 reference

Europe PubMed Central

4 July 2017

Wei Lu

9

1 reference

Europe PubMed Central

4 July 2017

language of work or name

0 references

publication date

20 June 2005

1 reference

Europe PubMed Central

4 July 2017

BMC Pharmacology

1 reference

Europe PubMed Central

4 July 2017

5

1 reference

Europe PubMed Central

4 July 2017

1

0 references

11

1 reference

Europe PubMed Central

4 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2210-5-11

0 references

Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180833

7 April 2017

Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180833

7 April 2017

The future of gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180833

28 September 2017

Dynamics of tumour angiogenesis: effect of razoxane-induced growth rate slowdown

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180833

28 September 2017

Probing the role of linker substituents in bisdioxopiperazine analogs for activity against wild-type and mutant human topoisomerase II alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180833

28 September 2017

Antiangiogenic and antivascular therapy for cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180833

28 September 2017

Biological properties of ICRF-159 and related bis(dioxopiperazine) compounds.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180833

28 September 2017

Radiotherapeutic enhancement by razoxane

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180833

28 September 2017

Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180833

28 September 2017

Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180833

28 November 2018

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180833

28 November 2018

Characterization of the biological and biochemical activities of F 11782 and the bisdioxopiperazines, ICRF-187 and ICRF-193, two types of topoisomerase II catalytic inhibitors with distinctive mechanisms of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/15963241

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15963241

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenesis. A boost for tumor starvation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15963241

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of anti-cancer drugs on the binding of 125I-Fibrinogen to two leukaemia cell lines in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/15963241

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Antineoplastic action and toxicity of probimane and its effect on immunologic functions in mice]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15963241

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Effects of bimolane and probimane on the incorporation of (3H)TdR, (3H)UR and (3H)Leu into Ehrlich ascites carcinoma cells iv vitro]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15963241

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Cytokinetic effects of 1,2-bis(4-isobutoxycarbonyloxymethyl-3,5- dioxopiperazin-1-yl) ethane (MST-16) on leukemia L1210 cells in mice]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15963241

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activities and schedule dependence of orally administered MST-16, a novel derivative of bis(2,6-dioxopiperazine)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15963241

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Distribution of 14C labeled at dioxopiperazine or methyl morpholine group of probimane by whole body autoradiography]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15963241

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15963241

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2210-5-11

1 reference

Europe PubMed Central

4 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 July 2017

1 reference

Europe PubMed Central

4 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24815007&oldid=1444271070"